Anzeige
Mehr »
Mittwoch, 25.02.2026 - Börsentäglich über 12.000 News
Winzig bewertet - und jetzt startet die heiße Phase mit Trigger-Fahrplan 2026
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 716460 | ISIN: DE0007164600 | Ticker-Symbol: SAP
Xetra
25.02.26 | 12:57
165,76 Euro
-0,05 % -0,08
1-Jahres-Chart
SAP SE Chart 1 Jahr
5-Tage-Chart
SAP SE 5-Tage-Chart
RealtimeGeldBriefZeit
165,80165,8413:13
165,78165,8413:13
PR Newswire
59 Leser
Artikel bewerten:
(0)

Health In Tech Inc.: Health In Tech Appoints Former SAP and IBM Executive Sri Rajagopalan as Chief Technology Officer to Advance AI-driven Enterprise-Grade Platform Growth

STUART, Fla., Feb. 24, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced the appointment of Sri Rajagopalan as Chief Technology Officer (CTO), effective February 23, 2026.

Mr. Rajagopalan has served as Health In Tech's Interim CTO since November 2025, during which time he has provided decisive technology leadership and advanced the company's AI-driven transformation strategy. As Interim CTO, he has strengthened architectural discipline, accelerated platform modernization, and delivered measurable execution across mission-critical technology initiatives.

As Chief Technology Officer, Mr. Rajagopalan oversees end-to-end product engineering and enterprise platform operations. He is responsible for advancing Health In Tech's next-generation technology architecture and AI development roadmap and embedding artificial intelligence, automation, and data intelligence across underwriting, claims, and benefits administration workflows. His mandate includes building, scaling, and optimizing the company's cloud-native, enterprise-grade platforms to enhance performance, security, interoperability, and scalability and position Health In Tech to execute on its long-term enterprise vision and forthcoming strategic growth initiatives.

Mr. Rajagopalan has more than two decades of enterprise-scale technology leadership, with global experience in software engineering, cloud transformation, data and AI platforms, and developing enterprise architecture frameworks that support large-scale operations.

Prior to joining Health In Tech, Mr. Rajagopalan spent the majority of his career at SAP and IBM, two of the world's leading enterprise software companies, where he held senior leadership roles in enterprise architecture and large-scale platform engineering. His experience spans global, mission-critical systems serving complex enterprise clients across multiple industries.

Since 2019, he has focused exclusively on the healthcare technology sector, serving as Senior Vice President of Software Engineering at Net Health, Senior Vice President of Platform Engineering at Zelis, and Vice President of Software Engineering & Chief Architect at Greenway Health. Across these roles, he led large engineering organizations, modernized core platforms, and scaled high-performance, transaction-intensive systems-bringing deep expertise in healthcare payments, claims technology, and data-driven platform transformation to Health In Tech.

"Sri's deep enterprise architecture and large-scale platform engineering experience comes at a pivotal moment in Health In Tech's evolution," said Tim Johnson, Chief Executive Officer of Health In Tech. "He has led global engineering organizations, modernized complex legacy systems, and delivered mission-critical infrastructure at true enterprise scale. As we expand our AI-enabled underwriting and benefits administration platform, Sri will strengthen our core technology foundation-enhancing scalability, data intelligence, cybersecurity, and operational resilience. We believe his leadership positions us to support larger carrier and broker partners, execute multiple strategic initiatives in parallel, and build the enterprise-grade infrastructure required for sustained long-term growth."

"Health In Tech is entering an exciting phase of technology acceleration," said Rajagopalan. "My priority is to scale a secure, cloud-native, AI-enabled platform architecture that supports high-volume transaction processing, advanced data analytics, and seamless ecosystem integrations. We will continue modernizing our engineering practices, strengthening data governance and security frameworks, and building a resilient, enterprise-class infrastructure capable of supporting rapid distribution expansion and product innovation. I look forward to leading our technology organization as we advance the next generation of Health In Tech's intelligent platform ecosystem."

Use of Forward-Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.

About Health In Tech

Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and third party administrators. Learn more at healthintech.com.

Investor Contact

Investor Relations:
[email protected]

SOURCE Health In Tech Inc.

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.